The potential for myocardial imaging with hypoxia markers

Seminars in Nuclear Medicine

Volumn 29, Issue 4, 1999, Pages 330-338

  Sinusas, A J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OXIME DERIVATIVE; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; UNCLASSIFIED DRUG; UPENAZIME;

ANGIOGENESIS; ARTICLE; CHEMICAL STRUCTURE; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; ISOTOPE LABELING; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TISSUE OXYGENATION;

EID: 0032877976     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(99)80020-8     Document Type: Article

References (46)

1. Battegay E Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects J Mol Med 73 1995 333 346
2. Shweiki D Itin A Soffer D Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis Nature 359 1992 843 845
3. Franko A Misonidazole and other hypoxia markers: Metabolism and applications Int J Radiat Oncol Biol Phys 12 1986 1195 1202
4. Chapman J Franko A Sharplin J A marker of hypoxic cells in tumors with potential clinical applicability Br J Cancer 43 1981 546 550
5. 3H]fluoromisomidazole in ischemic myocardium J Nucl Med 30 1989 194 201
6. Shelton M Dence C Hwang D Myocardial kinetics of fluorine-18 misonidazole: A marker J Nucl Med 30 1989 351 358
7. Shelton M Dence C Hwang D In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium J Am Coll Cardiol 16 1990 477 485
8. Martin G Caldwell J Graham M Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography J Nucl Med 33 1992 2202 2208
9. Strauss H Nunn A Linder K Nitroimidazoles for imaging hypoxic myocardium J Nucl Cardiol 2 1995 437 445
10. Linder K Cyr J Chan Y Effect of substituents on physiochemical and biological behavior of Tc-Pnao nitroimidazoles J Nucl Med 35 1994 18P
11. Martin G Cerqueira M Caldwell J Fluromisonidazole: A metabolic marker of myocyte hypoxia Circ Res 67 1990 240 244
12. Rumsey WL Cyr JE Raju N A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart Biochem Biophys Res Commun 193 1993 1239 1246
13. Rumsey WL Kuczynski B Patel B SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand J Nucl Med 36 1995 1445 1450
14. Rumsey W Patel B Linder K Effect of graded hypoxia on retention of technetium-99m-nitroheterocycle in perfused rat heart J Nucl Med 36 1995 632 636
15. Shi CQ Sinusas AJ Dione DP Technetium-99m-nitroimidazole (BMS181321): A positive imaging agent for detecting myocardial ischemia J Nucl Med 36 1995 1078 1086
16. Ng C Sinusas A Zaret B Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS181321), as a tracer for myocardial hypoxia Circulation 92 1995 1261 1268
17. Stone CK Mulnix T Nickles RJ Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion Circulation 92 1995 1246 1253
18. Kusuoka H Hashimoto K Fukuchi K Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium J Nucl Med 35 1994 1371 1376
19. Watanabe Y Kusuoka H Fukuchi K Contribution of hypoxia to the development of cardiomyopathy in hamsters Cardiovasc Res 35 1997 217 222
20. Weinstein H Reinhardt CP Leppo JA Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits J Nucl Med 39 1998 598 607
21. suppl Dahlberg S Gilmore M Flood M Effect of hypoxia and low flow ischemia on the myocardial extraction of technetium-99m-nitroimidazole Circulation 88 1993 1339
22. Fukuchi K Kusuoka H Watanabe Y Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole J Nucl Med 37 1996 761 766
23. Rumsey W Patel B Kuczynski B Comparison of two novel technetium agents for imaging ischemic myocardium Circulation 92 1995 1 181
24. Archer C Edwards B Kelly J Technetium labeled agents for imaging tissue hypoxia in vivo Nicolini M Bandoli G Mazzi U Technetium and Rhenium in Chemistry and Nuclear Medicine 1995 SGE Ditoriali Padova, Italy 535 539
25. Okada RD Johnson GR Nguyen KN 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent Circulation 95 1997 1892 1899
26. Dorantes T Carr J Dione D Evaluation of stunned myocardium with technetium-99m HL91: Comparison with tissue oxygen measurements Circulation 98 1998 I 96
27. Okada RD Johnson G III Nguyen KN 99mTc-HL91: “Hot spot” detection of ischemic myocardium in vivo by gamma camera imaging Circulation 97 1998 2557 2566
28. Johnson GI Nguyen K Liu Z Technetium-99m HL-91: A potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion J Nucl Cardiol 5 1998 285 294
29. Factor S Minase T Cho S Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis Circulation 66 1982 342 354
30. Davidoff A Gwathmey J Pathophysiology of cardiomyopathies. I. Animal models and humans Curr Opin Cardiol 9 1994 357 368
31. Nienaber C Gambhir S Mody F Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy Circulation 87 1993 1580 1590
32. Toussaint M Duboc D Lucet P Congestive cardiomyopathy and spasm of coronary microvasculatisation in man Ann Pathol 7 1987 223 226
33. Folkman J Shing Y Angiogenesis J Biol Chem 267 1992 10931 10934
34. Brogi E Wu T Namiki A Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only Circulation 90 1994 649 652
35. Kourembanas S Hannan R Faller D Oxygen tension regulates the expression of platelet-derived growth factor-B chain gene in human endothelial cells J Clin Invest 86 1990 670 674
36. Minchenko A Bauer T Salceda S Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo Lab Invest 71 1994 374 379
37. Sakuda H Nakashima Y Kuriyama S Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis: A relationship to transforming growth factor-B1 Am J Pathol 141 1992 1507 1516
38. Banai S Jaklitsch M Shou M Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs Circulation 89 1994 2183 2189
39. Mack C Patel S Schwarz E Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart J Thorac Cardiovasc Surg 115 1998 168 176
40. 165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
41. Ng C Sinusas A Kinetic analysis of technetium-99m HL-91 in isolated perfused rat hearts J Nucl Med 40 1999 88P
42. Knudson M Bermudez K Doyle C Use of tissue oxygen tension measurements during resuscitation from hemorrhagic shock J Trauma 42 1997 608 616
43. Grinberg O Grinberg S Friedman B Myocardial oxygen tension and capillary density in the isolated perfused rat heart during pharmacological intervention Nemoto La-Manna Oxygen Transport to Tissue XVIII 1997 Plenum New York, NY 171 181
44. Li D Dhawale P Rubin PJ Myocardial signal response to dipyridamole and dobutamine: Demonstration of the BOLD effect using a double-echo gradient-echo sequence Magn Reson Med 36 1996 16 20
45. Niemi P Poncelet BP Kwong KK Myocardial intensity changes associated with flow stimulation in blood oxygenation sensitive magnetic resonance imaging Magn Reson Med 36 1996 78 82
46. Shukla H Mason R Bansal N Regional oxygen tension: 19F MRI of sequestered perfluorocarbon Magn Reson Med 35 1996 827 833